Company: HSDTW
Filing Date: 2025-10-14
Form Type: DEF 14A
Source: 0001104659-25-098889
Chunk: 4

Company: Solana Co
Filing Date: 2025-10-14
Form: DEF 14A
Chunk 4
---
 | ​ | ​ |  31 | ​ | ​ |
| ​ | PROPOSAL 5 — ADJOURNMENT OF SPECIAL MEETING                           | ​ | ​ | ​ | ​ |  40 | ​ | ​ |
| ​ | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT        | ​ | ​ | ​ | ​ |  41 | ​ | ​ |
| ​ | DOCUMENTS INCORPORATED BY REFERENCE                                   | ​ | ​ | ​ | ​ |  43 | ​ | ​ |
| ​ | ADDITIONAL MATTERS                                                    | ​ | ​ | ​ | ​ |  43 | ​ | ​ |
| ​ | APPENDIX A — AMENDMENT 3 TO 2022 EQUITY INCENTIVE PLAN                | ​ | ​ | ​ | ​ | A-1 | ​ | ​ |

i

TABLE OF CONTENTS SOLANA COMPANY (F/K/A HELIUS MEDICAL TECHNOLOGIES, INC.)
PROXY STATEMENT 2025 SPECIAL MEETING OF STOCKHOLDERS
October 30, 2025 QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING Who is soliciting my vote? The Board of Directors (the “ Board ”) of Solana Company (f/k/a Helius Medical Technologies, Inc.) (the “ Company ”, “ we ” or “ us ”) is soliciting your proxy, as a holder of our Class A common stock (the “ Common Stock ”), for use at the special meeting of stockholders to be held on October 30, 2025, at 10:00 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/HSDT2025SM2 and any adjournment or postponement of such meeting (the “ Special Meeting ”). The Notice of Special Meeting of Stockholders (the “ Notice ”), proxy statement and form of proxy card are expected to be first mailed to stockholders of record on or about October 14, 2025. What is the purpose of the Special Meeting? At the Special Meeting, you will be voting on: • Proposal 1: To elect one new director to our Board of Directors; • Proposal 2: To approve, in accordance with Nasdaq Listing Rule 5635(a), the issuance of shares of our common stock upon the exercise of the Strategic Advisor Warrants issued to Pantera Capital Management LP and Summer Wisdom Holdings Limited; • Proposal 3